Literature DB >> 6991415

Correlation of the duration and magnitude of protection against Salmonella infection afforded by various vaccines with antibody titers.

C R Angerman, T K Eisenstein.   

Abstract

Groups of mice were immunized with optimal doses of the following vaccines of Salmonella typhimurium W118-2: acetone-killed cells, lipopolysaccharide, ribosomes, and live cells. At 3 weeks, 1 month, 2 months, 4 months, or 6 months postimmunization, sera were collected from control and vaccinated animals, and the anti-lipopolysaccharide and whole-cell agglutination titers of the sera were determined. Other groups of similarly vaccinated mice were tested for resistance to infection by challenging with live W118-2 and scoring the number of survivors 30 days postinfection. It was found that only ribosomes and live cells afforded significant protection 6 months after immunization. Thus, in duration of protection ribosomes were superior to the other nonviable vaccines tested. At all time intervals tested, purified lipopolysaccharide was the least effective vaccine. Protection afforded by the acetone-killed cell and ribosomal vaccines correlated better with the whole-cell agglutination titers than with the anti-lipopolysaccharide titers. However, the longer duration of protection afforded by the ribosomal vaccine, as compared with the acetone-killed vaccine, could not be accounted for by differences in whole-cell agglutination titers. These studies show that ribosomal vaccines are equal in all parameters to acetone-killed cells and have the advantage of providing longer-lasting immunity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6991415      PMCID: PMC550784          DOI: 10.1128/iai.27.2.435-443.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Oral immunization against experimental salmonellosis I. Development of temperature-sensitive mutant vaccines.

Authors:  K J Fahey; G N Cooper
Journal:  Infect Immun       Date:  1970-03       Impact factor: 3.441

2.  Long-term adjuvant effect of bacterial endotoxin in prevention and restoration of radiation-caused immunosuppression.

Authors:  U H Behling; A Nowotny
Journal:  Proc Soc Exp Biol Med       Date:  1978-03

3.  Immunity in experimental salmonellosis. 3. Comparative immunization with viable and heat-inactivated cells of Salmonella typhimurium.

Authors:  R Germanier
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

4.  Extraction and isolation of individual ribosomal proteins from Escherichia coli.

Authors:  S Fogel; P S Sypherd
Journal:  J Bacteriol       Date:  1968-08       Impact factor: 3.490

5.  Two types of immunity in experimental typhoid; "cellular immunity" and "humoral immunity".

Authors:  D Ushiba
Journal:  Keio J Med       Date:  1965-06

6.  Immune adjuvancy of lipopolysaccharide and a nontoxic hydrolytic product demonstrating oscillating effects with time.

Authors:  U H Behling; A Nowotny
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

7.  Evidence for O antigens as the antigenic determinants in "ribosomal" vaccines prepared from Salmonella.

Authors:  T K Eisenstein
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

8.  Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium.

Authors:  M R Venneman; N J Bigley
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

9.  Comparative efficacy and toxicity of a ribosomal vaccine, acetone-killed cells, lipopolysaccharide, and a live cell vaccine prepared from Salmonella typhhimurium.

Authors:  C R Angerman; T K Eisenstein
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

10.  Host-parasite relations in mouse typhoid.

Authors:  G B Mackaness; R V Blanden; F M Collins
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  20 in total

1.  Increased sensitivity to Salmonella enterica serovar Typhimurium infection in mice undergoing withdrawal from morphine is associated with suppression of interleukin-12.

Authors:  Pu Feng; Qiana M Wilson; Joseph J Meissler; Martin W Adler; Toby K Eisenstein
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Analysis of immunity to infection with Salmonella typhimurium in outbred mice. II. Isolation and immunogenicity of the protective non-O antigenic component from ribosomal vaccine.

Authors:  E Kita; M Emoto; N Katsui; K Nishi; K Yasui; K Yasui; S Kashiba
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

3.  Protective immunity induced by outer membrane proteins of Salmonella typhimurium in mice.

Authors:  V Udhayakumar; V R Muthukkaruppan
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

4.  Immunomodulation of the antibody response to lipopolysaccharide in C3H/HeJ mice by complexing with heterologous ribosomes.

Authors:  M Phillips; T K Eisenstein; J Meissler
Journal:  Infect Immun       Date:  1985-04       Impact factor: 3.441

Review 5.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors:  M M Levine; J B Kaper; R E Black; M L Clements
Journal:  Microbiol Rev       Date:  1983-12

6.  Physical and morphological characteristics of eucaryotic ribosomes and lipopolysaccharide complexes.

Authors:  M Phillips; K A Brogden
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

7.  Phase variation of the lpf operon is a mechanism to evade cross-immunity between Salmonella serotypes.

Authors:  T L Norris; A J Bäumler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

8.  Antigenic role of stress-induced catalase of Salmonella typhimurium in cell-mediated immunity.

Authors:  K Kagaya; Y Miyakawa; K Watanabe; Y Fukazawa
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

9.  Antibody response and protection against challenge in mice vaccinated intraperitoneally with a live aroA O4-O9 hybrid Salmonella dublin strain.

Authors:  A A Lindberg; T Segall; A Weintraub; B A Stocker
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

10.  Cellular aspects of the longer-lasting immunity against mouse typhoid infection afforded by the live-cell and ribosomal vaccines.

Authors:  E Kita; M Emoto; K Yasui; K Yasui; N Katsui; K Nishi; S Kashiba
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.